Additionally, the increase in CCL2/CXCL10 and CCL3/CXCL10 ratios has been observed in the CSF of CM patients with neurological deteriorations who subsequently developed CM-IRIS on ART [102]. This evidence concerns the gene CXCL10 and cutaneous mastocytosis.